Highlights one of the most remarkable achievements of Spanish Biotechs. Leading together with a great team, the discovery and development of a first-in-class vascular calcification inhibitor, I guided it from early preclinical research through Phase 3 trials, describing the MOA, dose and safety rational as building the preclinical regulatory support, proving resilience, persistence, and scientific excellence under challenging conditions.